Log in to save to my catalogue

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infecti...

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infecti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003867

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

About this item

Full title

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

Publisher

New York: Nature Publishing Group US

Journal title

Nature immunology, 2024-04, Vol.25 (4), p.633-643

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Vaccines have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) morbidity and mortality, yet emerging variants challenge their effectiveness. The prevailing approach to updating vaccines targets the antibody response, operating under the presumption that it is the primary defense mechanism following vaccination or infection. This...

Alternative Titles

Full title

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003867

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003867

Other Identifiers

ISSN

1529-2908,1529-2916

E-ISSN

1529-2916

DOI

10.1038/s41590-024-01787-z

How to access this item